Showing results (41-50 of 195) with videos related to
Sort By:
Pageof 20
European Journal of Clinical Pharmacology|January 1, 1996
What have the ACE-inhibitor trials in postmyocardial patients with left ventricular dysfunction taught us?G Reynolds, A S Hall, S G BallJournal of Molecular Endocrinology|October 29, 1997
3,5-Diiodo-L-thyronine (T2) has selective thyromimetic effects in vivo and in vitroS G Ball, J Sokolov, W W ChinBehaviour Research and Therapy|January 1, 1996
Symptom subtypes of obsessive-compulsive disorder in behavioral treatment studies: a quantitative reviewS G Ball, L Baer, M W OttoJournal of Clinical Pathology|January 1, 1989
Renal impairment in myeloma: negative association with isoelectric point of excreted Bence-Jones proteinA G Norden, F V Flynn, L M Fulcher, et al.Annals of Clinical Biochemistry|September 1, 1986
Bence Jones protein detection: a rapid immunoblotting technique for routine use on unconcentrated urineA D Heys, A G Norden, L M Fulcher, et al.Lancet (London, England)|April 2, 1977
Failure of saralasin to predict a response to surgery in renovascular hypertensionR D Thomas, S G Ball, M R LeeJournal of Neurochemistry|April 1, 1993
Effect of inhibitors of eicosanoid metabolism on release of [3H]noradrenaline from the human neuroblastoma, SH-SY5YP F Vaughan, M G Murphy, S G BallNeuroscience Letters|August 19, 1991
The effect of calcium channel antagonists on the release of [3H]noradrenaline in the human neuroblastoma, SH-SY5YN P Murphy, S G Ball, P F VaughanCellular Signalling|April 18, 2001
The mechanism of angiotensin II-induced extracellular signal-regulated kinase-1/2 activation is independent of angiotensin AT(1A) receptor internalisationN A Turner, S G Ball, A J BalmforthJournal of the American College of Cardiology|June 1, 1995
Angiotensin-converting enzyme inhibitors after myocardial infarction: indications and timingS G Ball, A S Hall, G D MurrayPageof 20